Kane Biotech Inc. (KNBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0328
0.00 (0.00%)
Sep 25, 2025, 8:00 PM EDT
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of $5.96 million as of September 29, 2025. Its market cap has decreased by -53.20% in one year.
Market Cap
5.96M
Enterprise Value
6.66M
Revenue
1.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 764.76K to 5.96M, an increase of 679.47%. That is a compound annual growth rate of 9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 5.96M | -43.30% |
| Dec 31, 2024 | 10.51M | 31.63% |
| Dec 29, 2023 | 7.99M | -3.79% |
| Dec 30, 2022 | 8.30M | -40.97% |
| Dec 31, 2021 | 14.06M | 17.84% |
| Dec 31, 2020 | 11.93M | 8.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 742.59M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 516.60M |
| Northwest Biotherapeutics | 387.17M |
| CytoDyn | 332.57M |
| American Oncology Network | 305.31M |
| Nika Pharmaceuticals | 301.74M |